Back to search

Article

Prognostic and immunological potential of AC012236.1/hsa-miR-30d-5p ceRNA AVEN by integrated analysis of single-cell and bulk RNA-seq in lung adenocarcinoma

2025-11-01

Abstract excerpt

<title>Abstract</title> <p>Lung adenocarcinoma (LUAD) is the most prevalent histological subtype of non-small cell lung cancer (NSCLC) and is characterized by high mortality and limited therapeutic efficacy in advanced stages. AVEN, an apoptosis inhibitor that interacts with Bcl-xL and Apaf-1 to suppress caspase activation, has been implicated in tumour progression and drug resistance in various cancers. However,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bd820646-ae32-5306-ae34-6723166d326c
DOI
10.21203/rs.3.rs-5071092/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prognostic and immunological potential of AC012236.1/hsa-miR-30d-5p ceRNA AVEN by integrated analysis of single-cell and bulk RNA-seq in lung adenocarcinomaDOI 10.21203/rs.3.rs-5071092/v1
Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Data to Establish and Validate a Prognostic Model for Patients With Lung AdenocarcinomaSemantic proximity
Characterizing Tumor Microenvironment and Risk Genes in Lung Adenocarcinoma through scRNA-seq and Bulk RNA-seq DataSemantic proximity
Integrated single-cell and bulk RNA-Seq analysis enhances prognostic accuracy of PD-1/PD-L1 immunotherapy response in lung adenocarcinoma through necroptotic anoikis gene signaturesSemantic proximity
Landscape and dynamics of single tumor and immune cells in early and advanced‐stage lung adenocarcinomaSemantic proximity
Identification of a novel necroptosis-related lncRNA-based prognostic model and immunological characteristics of Lung AdenocarcinomaSemantic proximity
A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung AdenocarcinomaSemantic proximity
Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals immune suppression subtypes and establishes a novel signature for determining the prognosis in lung adenocarcinomaSemantic proximity
Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung AdenocarcinomaSemantic proximity
HILPDA: A Novel Prognostic Biomarker for Lung Adenocarcinoma Identified by Integrated Bioinformatic Analysis and Experimental ValidationSemantic proximity
IncRNA VIM-AS1 expression is positively correlated with the prognosis and immune infiltration in lung adenocarcinomaSemantic proximity
An RNA Modification–Associated Gene-Based Prognostic Model and Its Relevance to the Immune Microenvironment and Therapeutic Response in Lung AdenocarcinomaSemantic proximity
A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblastsSemantic proximity
Select a neighboring publication to make it the new centre.